Clinical Trials at Harlem Cardiology
During the past decade, Harlem Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Harlem Cardiology"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Harlem Cardiology
According to Clinical.Site data, the most researched conditions in "Harlem Cardiology" are
"Heart Failure" (2 trials) and "Tachycardia" (1 trials). Many other conditions were trialed in "Harlem Cardiology" in a lesser frequency.
Clinical Trials Intervention Types at Harlem Cardiology
Most popular intervention types in "Harlem Cardiology" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials) and "PARADYM DR model 8550; PARADYM CRT model 8750; PARADYM RF DR model 9550; PARADYM RF CRT model 9750; PARADYM RF CRT SonR model 9770" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Harlem Cardiology
The vast majority of trials in "Harlem Cardiology" are
3 trials for "All" genders.
Clinical Trials Status at Harlem Cardiology
Currently, there are NaN active trials in "Harlem Cardiology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Harlem Cardiology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Harlem Cardiology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".